Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Average Target - West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Evolution of the Target Price - West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

9e622dd939214f03e32a7e44fe.OYtOwowSDGcyVHDXDfQ6C7BExckiz0cV4TCgKYP1LnQ.VewDrN90YjV5HCHhfbkPboYS9Llmp3JeqGfGe-62dyZMxjqU3V1qX3QEAw~184b96accc3afbda6c0f6a2ecfd68ea7
03/11 Jefferies Adjusts West Pharmaceutical Services Price Target to $475 From $410 MT
31/10 Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450 MT
31/10 Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy Rating MT
30/10 BNP Paribas Adjusts Price Target on West Pharmaceutical Services to $466 From $459 MT
30/10 Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $480 From $410 MT
29/10 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $425 From $440 MT
14/10 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410 MT
08/10 Evercore ISI Adjusts West Pharmaceutical Services Price Target to $440 From $410 MT
06/10 Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating MT
23/09 West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says MT
22/09 Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 MT
09/09 UBS Raises Price Target on West Pharmaceutical Services to $415 From $340, Keeps Buy Rating MT
27/07 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
27/07 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
24/07 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
24/07 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
24/07 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
20/07 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
16/07 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
14/07 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
13/07 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
10/07 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
06/07 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
02/07 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
09/06 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+13.11%
+9.57%
+2.08%
+9.6%
+18.41%
+6.51%
+3.72%
+1.84%
+27.74%
+20.55%
Average +11.31%
Weighted average by Cap. +9.91%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
416.42USD
Average target price
471.00USD
Spread / Average Target
+13.11%
High Price Target
500.00USD
Spread / Highest target
+20.07%
Low Price Target
340.00USD
Spread / Lowest Target
-18.35%

Analyst Consensus Detail

Analyst consensus - West Pharmaceutical Services, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - West Pharmaceutical Services, Inc.
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Consensus West Pharmaceutical Services, Inc.